Free Trial

Teleflex Incorporated (NYSE:TFX) Holdings Decreased by Charles Schwab Investment Management Inc.

Teleflex logo with Medical background

Charles Schwab Investment Management Inc. trimmed its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 6.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 398,678 shares of the medical technology company's stock after selling 27,705 shares during the period. Charles Schwab Investment Management Inc. owned about 0.86% of Teleflex worth $98,601,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also made changes to their positions in the company. O Shaughnessy Asset Management LLC increased its holdings in shares of Teleflex by 26.3% during the 1st quarter. O Shaughnessy Asset Management LLC now owns 2,313 shares of the medical technology company's stock valued at $523,000 after purchasing an additional 482 shares in the last quarter. Tidal Investments LLC lifted its stake in Teleflex by 214.7% in the 1st quarter. Tidal Investments LLC now owns 6,644 shares of the medical technology company's stock valued at $1,503,000 after buying an additional 4,533 shares in the last quarter. Comerica Bank boosted its holdings in Teleflex by 13.0% in the 1st quarter. Comerica Bank now owns 14,491 shares of the medical technology company's stock worth $3,277,000 after buying an additional 1,662 shares during the last quarter. iA Global Asset Management Inc. increased its stake in Teleflex by 11.0% during the 1st quarter. iA Global Asset Management Inc. now owns 3,136 shares of the medical technology company's stock worth $709,000 after buying an additional 311 shares in the last quarter. Finally, Plato Investment Management Ltd acquired a new position in shares of Teleflex during the first quarter valued at approximately $297,000. Institutional investors own 95.62% of the company's stock.

Analyst Upgrades and Downgrades

TFX has been the topic of several recent research reports. Royal Bank of Canada lowered their price target on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Truist Financial reiterated a "hold" rating and issued a $227.00 price objective (down from $255.00) on shares of Teleflex in a research note on Monday, November 4th. Needham & Company LLC reiterated a "hold" rating on shares of Teleflex in a report on Friday, November 1st. Mizuho dropped their price objective on Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a report on Friday, November 1st. Finally, StockNews.com cut shares of Teleflex from a "buy" rating to a "hold" rating in a research report on Wednesday, November 20th. Four research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $259.25.

Get Our Latest Report on TFX

Teleflex Stock Up 0.7 %

Shares of TFX stock traded up $1.27 on Wednesday, hitting $192.28. The stock had a trading volume of 17,153 shares, compared to its average volume of 380,647. Teleflex Incorporated has a 52-week low of $185.66 and a 52-week high of $257.85. The firm has a market capitalization of $8.93 billion, a price-to-earnings ratio of 37.98, a P/E/G ratio of 1.99 and a beta of 1.18. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The stock's 50 day moving average is $222.95 and its 200-day moving average is $222.87.

Teleflex (NYSE:TFX - Get Free Report) last released its earnings results on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, topping analysts' consensus estimates of $3.38 by $0.11. The company had revenue of $764.40 million for the quarter, compared to the consensus estimate of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Teleflex's quarterly revenue was up 2.4% compared to the same quarter last year. During the same quarter last year, the business posted $3.64 EPS. As a group, research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date is Friday, November 15th. Teleflex's dividend payout ratio is currently 27.04%.

Teleflex Company Profile

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Recommended Stories

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Should you invest $1,000 in Teleflex right now?

Before you consider Teleflex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.

While Teleflex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

MicroStrategy Stock: Riding Bitcoin’s Wave to New Highs
How Abacus Life is Transforming Life Insurance into Assets | MarketBeat CEO Series
NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines